NOVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Novanta Inc. (NOVT) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown positive financial growth and an optimistic outlook, the technical indicators and options data suggest a neutral to slightly bearish sentiment. Additionally, insider selling by the CEO and the lack of strong trading signals further support a hold recommendation.
The MACD is negative and expanding (-1.487), indicating bearish momentum. RSI is neutral at 39.222, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level of 140.558, with key support at 132.937 and resistance at 148.179.
Hedge funds are increasing their positions, with a 140% rise in buying activity over the last quarter. The company reported record Q4 revenue of $258 million, a 9% YoY growth, and provided an optimistic outlook for FY 2026.
The CEO sold 7,500 shares, reducing his direct holdings by 6.29%. Technical indicators suggest bearish momentum, and the stock has a 50% chance of a slight decline (-0.09%) in the next day. Gross margin dropped by 4.71% YoY, and EPS declined by 2.17% YoY.
In Q4 2025, revenue increased by 8.52% YoY to $258.3 million, and net income rose by 6.12% YoY to $17.47 million. However, EPS dropped by 2.17% YoY to 0.45, and gross margin decreased to 40.7%, down 4.71% YoY.
Baird analyst Robert Mason raised the price target to $150 from $138, maintaining a Neutral rating. Analysts expect accelerating sales and margins, but the neutral rating reflects a cautious stance.
